CARE Ratings FY26 Profit ₹173.7Cr; Dividend ₹14/Share Declared

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorAkshat Lakshkar|Published at:
CARE Ratings FY26 Profit ₹173.7Cr; Dividend ₹14/Share Declared
Overview

CARE Ratings announced audited FY26 financials, reporting ₹473.07 crore revenue and ₹173.70 crore net profit. The board recommended a final dividend of ₹14 per share and plans to re-appoint BSR & Co. LLP as statutory auditors for five years. Stake sale talks for subsidiary CareEdge Global IFSC are ongoing but delayed.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

CARE Ratings FY26: Profit Hits ₹173.7 Cr, ₹14 Dividend Declared

Audited consolidated revenue for the year ended March 31, 2026, reached ₹473.07 crore, with net profit climbing to ₹173.70 crore.
Reader Takeaway: Profit hit ₹173cr on steady revenue; stake sale delay casts a shadow.

What just happened (today’s filing)

CARE Ratings' Board of Directors met on May 13, 2026, to approve the audited financial results for the fiscal year ending March 31, 2026.

The company recommended a final dividend of ₹14 per equity share for FY26, subject to shareholder approval at the upcoming AGM.

Key decisions also included the proposed re-appointment of BSR & Co. LLP as Statutory Auditors for a five-year term and the grant of 55,000 stock options under the 'CARE Employee Stock Option Scheme 2020'.

Why this matters

The dividend payout directly benefits shareholders, reflecting the company's profitability and commitment to returning value.

Re-appointing BSR & Co. LLP ensures continuity in financial oversight and audit, crucial for market confidence.

The approved ESOPs aim to align employee interests with long-term company performance and retention.

The backstory (grounded)

CARE Ratings operates as a leading credit rating agency in India, assessing the creditworthiness of various debt instruments.

The company has a history of paying dividends and has been strategically evaluating its business portfolio, including the potential divestment of non-core assets or subsidiaries.

What changes now

Shareholders can anticipate a ₹14 per share final dividend for FY26, enhancing their returns.

Financial reporting and audit processes are set for continuity with the proposed five-year auditor reappointment.

Employee incentives are bolstered through the allocation of stock options, fostering a sense of ownership.

Risks to watch

The ongoing negotiations for the stake sale in CareEdge Global IFSC Limited are facing delays, potentially impacting strategic objectives or deal realization timelines.

Peer comparison

CARE Ratings competes with other major Indian credit rating agencies like CRISIL Limited and ICRA Limited.

CRISIL is known for its broad range of financial services, while ICRA is another established rating agency.

Context metrics (time-bound)

  • Consolidated Revenue from Operations stood at ₹473.07 crore in FY26, a slight decrease from ₹475.42 crore in FY25.
  • Consolidated Net Profit was ₹173.70 crore in FY26, down from ₹179.73 crore in FY25.

What to track next

Shareholders will vote on the re-appointment of BSR & Co. LLP as Statutory Auditors at the AGM.

Progress on the stake sale discussions for CareEdge Global IFSC Limited will be closely monitored.

The outcome and key discussions from the 33rd Annual General Meeting on July 3, 2026.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.